Back to 
Carlyle Group Inc.
Carlyle Group Inc.
RPHM
Showing 2 of 8 quarters
Position history for Carlyle Group Inc.'s holdings in RENEO PHARMACEUTICALS INC
As of its Q3 2024 13F, Carlyle Group held 2,698,957 shares of RPHM (Reneo Pharmaceuticals), worth $4.5M. Carlyle Group's 13F filings listed RPHM from Q1 2023 to Q3 2024, 7 quarterly filings. RPHM was 0.5% of Carlyle Group's reported 13F portfolio.
Final Value
$0
Final Shares
0
Total Value Change
-$4.5M
Total Shares Change
-2.7M
Quarter-by-Quarter History